Morgan Ebert, Managing Editor

Large Korean study finds no link between prenatal or infant antibiotic exposure and autoimmune disease risk in children.

Higher omega-3 intake may protect children from myopia, while diets high in saturated fats may raise risk, study finds.

Immune surveillance study shows pandemic interventions suppressed viral exposure in children, driving post-COVID resurgence and future outbreak risk.

In recent studies, donidalorsen (Dawnzera) has demonstrated durable efficacy and long-term disease control.

Low-dose methylprednisolone is as effective as high-dose for severe pediatric MPP and has fewer side effects, supporting safer treatment strategies.

Controlling childhood EoE inflammation improves esophageal flexibility, reduces dysphagia risk, and may predict need for stricture dilation.

High-dose centanafadine significantly improved ADHD symptoms in children aged 6 to 12 years and was well tolerated, according to findings from a phase 3 clinical trial.

Biennial HPV testing and higher vaccination rates could help South Korea eliminate cervical cancer up to a decade earlier than current policy.

AAP updates guidance on recognizing and managing iatrogenic opioid dependence and withdrawal in children prescribed opioids.

Survey finds 30% of children missing school due to anxiety miss over a week; experts urge early intervention and therapy to address school avoidance.

Higher maternal vitamin D in early pregnancy linked to better fluid and overall cognition in children, especially among those of Black mothers.

FDA approves first generic iron sucrose injection for treating iron deficiency anemia in CKD patients 2 years and older.

FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients ≥12 years.

Pharmacotherapy use for pediatric obesity rose after AAP’s 2023 guidelines, though overall rates remain low compared to nutrition counseling.

A US study finds influenza-associated necrotizing encephalopathy in children has high mortality and disability, underscoring need for early care.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from July 2025.

Take a quick look at everything you may have missed last month, including the top FDA approvals and latest clinical updates.

The FDA approved concizumab-mtci (Alhemo; Novo Nordisk) for hemophilia A/B without inhibitors, offering once-daily subcutaneous prophylaxis that significantly reduces bleeding rates.

Pediatricians are urged to follow 2024 guidelines amid ACIP upheaval, vaccine hesitancy, and access issues as children head back to school.

Many families face common potty training challenges, including anxiety and setbacks, highlighting the need for patience and personalized strategies.

The FDA has approved avatrombopag and new sprinkle formulation for children ≥1 year with chronic ITP, offering an oral, food-flexible treatment option.

Most youth with type 1 diabetes in sub-Saharan Africa lack autoimmune markers, suggesting a distinct, non-autoimmune form of insulin-deficient diabetes.

Nirsevimab reduced RSV-related illness by up to 98% and lowered the amount of hospitalizations and health care use among healthy term infants in a real-world study.

A new polygenic risk score enhances obesity risk prediction from childhood to adulthood, offering new insights for early intervention and prevention strategies.

U.S. public schools enhance student mental health support through screenings, yet face challenges in ensuring effective follow-up care and resources.

Childhood cardiovascular health is crucial for lifelong benefits, enhancing cognitive, metabolic, and mental well-being while reducing disease risks.

Early antibiotic exposure disrupts infant immune development by altering gut microbiota, highlighting inosine's potential as a therapeutic target for immune restoration.

A recent study reveals a staggering 763% rise in nicotine pouch ingestions among young children, highlighting urgent public health concerns.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

The FDA approves gardenia (genipin) blue as a natural food color, enhancing options for manufacturers and supporting the shift away from synthetic dyes.